Disrupted eye movements in preperimetric primary open-angle glaucoma by Najjar, Raymond P. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Disrupted eye movements in preperimetric primary open-angle glaucoma
Najjar, Raymond P.; Sharma, Sourabh; Drouet, Morgane; Leruez, Stephanie; Baskaran,
Mani; Nongpiur, Monisha E.; Aung, Tin; Fielding, Joanne; White, Owen; Girard, Michael J.;
Lamirel, Cédric; Milea, Dan
Published in:
Investigative Ophthalmology and Visual Science
DOI:
10.1167/iovs.16-21002
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY-NC-ND
Citation for published version (APA):
Najjar, R. P., Sharma, S., Drouet, M., Leruez, S., Baskaran, M., Nongpiur, M. E., ... Milea, D. (2017). Disrupted
eye movements in preperimetric primary open-angle glaucoma. Investigative Ophthalmology and Visual
Science, 58(4), 2430-2437. https://doi.org/10.1167/iovs.16-21002
Download date: 03. Feb. 2020
Glaucoma
Disrupted Eye Movements in Preperimetric Primary Open-
Angle Glaucoma
Raymond P. Najjar,1,2 Sourabh Sharma,1,3 Morgane Drouet,4 Stephanie Leruez,4 Mani
Baskaran,1–3 Monisha E. Nongpiur,1–3 Tin Aung,1,3,5 Joanne Fielding,6–8 Owen White,6–8 Michael
J. Girard,1,9 Ce´dric Lamirel,10 and Dan Milea1–4,11
1Singapore Eye Research Institute, Singapore
2The Ophthalmology and Visual Sciences Academic Clinical Program, Duke-National University of Singapore Medical School,
Singapore
3Singapore National Eye Centre, Singapore
4Department of Ophthalmology, Angers University Hospital, Angers, France
5Yong Loo Lin School of Medicine, National University of Singapore, Singapore
6Department of Neurology, Royal Melbourne Hospital, Parkville, Australia
7Department of Medicine, University of Melbourne, Parkville, Australia
8School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Clayton,
Australia
9Ophthalmic Engineering and Innovation Laboratory, Department of Biomedical Engineering, Faculty of Engineering, National
University of Singapore, Singapore
10Fondation Ophtalmologique Rothschild, Paris, France
11Ophthalmology Department, Glostrup University Hospital, University of Copenhagen, Denmark
Correspondence: Dan Milea, Singa-
pore National Eye Centre, 11 Third
Hospital Avenue, Singapore 168751;
dan.milea@snec.com.sg.
CL and DM are joint senior authors.
Submitted: October 27, 2016
Accepted: March 27, 2017
Citation: Najjar RP, Sharma S, Drouet
M, et al. Disrupted eye movements in
preperimetric primary open-angle
glaucoma. Invest Ophthalmol Vis Sci.
2017;58:2430–2437. DOI:10.1167/
iovs.16-21002
PURPOSE. Primary open-angle glaucoma (POAG) can be associated with abnormal ocular motor
behavior, possibly as a compensatory strategy following visual field loss. The aim of this study
was to explore the characteristics of saccadic eye movements in patients with early-stage
POAG without any detectable glaucomatous visual field loss (i.e., preperimetric POAG).
METHODS. Binocular eye movements were explored in 16 patients with bilateral preperimetric
POAG and 16 age-matched healthy controls in a cross-sectional, observational study. Visually
guided horizontal prosaccades (58, 108, 158, and 208 amplitude) and antisaccades (128
amplitude) were measured using infrared oculography. The latency, average and peak
velocities, amplitude and gain of prosaccades as well as the percentage of errors in the
antisaccades task were compared between groups.
RESULTS. POAG patients exhibited a reduced average velocity of saccades compared to
controls across all amplitudes of peripheral visual target presentation (P ¼ 0.03). Saccades
performed by POAG patients were hypometric, and with reduced amplitude (P ¼ 0.007) and
gain (P ¼ 0.01) compared to controls. On average, POAG patients displayed more antisaccade
errors (40.6%), as compared to controls (23.4%; P ¼ 0.04).
CONCLUSIONS. Here, we show that patients with POAG without detectable glaucomatous visual
field loss exhibit altered saccadic eye movements. These abnormalities may indicate
disordered cortical and subcortical saccadic regulation, either on the basis of subthreshold
visual impairment, or as a result of wider disease-associated neurodegeneration. Additional
studies, controlling for glaucoma medications, are required to delineate the neural basis of eye
movement abnormalities associated with POAG.
Keywords: primary open-angle glaucoma, preperimetric, eye movements, prosaccades,
antisaccades, infrared oculography
Primary open-angle glaucoma (POAG) is a multifactorialprogressive optic neuropathy that leads to an irreversible,
yet gradual, visual field loss. It is characterized by axonal
degeneration affecting the afferent visual pathways, from the
retinal ganglion cells (RGCs) to the lateral geniculate nucleus
(LGN) and visual cortex.1–9 In addition to the visual system
involvement, recent brain functional connectivity studies have
suggested that various nonvisual cerebral areas could also be
affected in glaucoma, as part of a more global neurodegener-
ation.10,11 These affected regions include cortical and subcor-
tical areas involved in the control of ocular motor behavior.12–17
Published reports on eye movements in glaucoma have
already suggested that eye movements and visual exploratory
behavior are altered in the disease. While some studies have
shown that POAG patients with visual field defects perform
more saccades compared to healthy controls when viewing a
traffic video displayed on a computer screen or performing
familiar and unfamiliar tasks,18,19 others reported that POAG
patients with visual field defects perform less saccades than
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controls when viewing computer displayed photographs of
everyday scenes.20 In addition to protocol differences,
discrepancies between these studies could arise from dissim-
ilarities in visual field loss/sensitivity between patients,21 as
well as unpredictable adaptive oculomotor behaviors to
compensate for visual field loss.22–24 Compensatory oculomo-
tor behavior, however, may not be the sole mechanism
contributing to aberrant eye movements in POAG, as excessive
saccades have also been reported when visual targets were
displayed into unaffected visual field areas in POAG patients.25
Furthermore, preliminary findings by Lamirel and colleagues,25
suggest that saccadic eye movements can be altered at very
early stages of POAG, with no detectable visual field deficit.
In an attempt to reduce the contribution of visual field loss
as a potential confounding factor in the evaluation of ocular
motor behavior in glaucoma, here we study saccadic eye
movement abnormalities in patients with POAG, in whom
structural damages (i.e., neuronal loss detectable via optical
coherence tomography) were not associated with detectable
functional deterioration in the visual fields. These patients are
often referred to in the literature as preperimetric glaucoma
patients.26
MATERIALS AND METHODS
Participants
Sixteen patients diagnosed with bilateral preperimetric POAG
and 16 age-matched healthy controls were included in this
cross-sectional observational study. Patients and controls
underwent a comprehensive ophthalmic examination that
comprised slit-lamp examination (Model 900 BQ, Haag-Streit,
Bern, Switzerland), best-corrected visual acuity (BCVA; logMAR
chart), automated refraction (Canon RK 5 Auto Ref-Keratom-
eter; Canon, Tochigiken, Japan), intraocular pressure (IOP)
measurement (Goldmann applanation tonometer, Haag-Streit),
gonioscopy (Sussman four mirror lens, Ocular Instruments,
Bellevue, WA, USA), and baseline peripapillary retinal nerve
fiber layer (RNFL) thickness via high definition optical
coherence tomography (HD-OCT; Cirrus version 6.0, Carl
Zeiss Meditec, Dublin, CA, USA). OCT results were validated
only if the recorded signal strength had a value of 6 or better.
The visual fields of all participants were assessed on two
separate visits, at least 6 months apart, using the Humphrey
visual field analyzer II (Carl Zeiss Meditec) with the Swedish
Interactive Thresholding Algorithm (SITA fast 24-2 strategy
[stimulus size III]). Repeated testing was performed if the rates
of false-positive or false-negative responses were greater than
30%, or if the fixation loss rate was greater than 20%.
Participants who did not achieve these levels of performance
on repeat testing were excluded from the study. Details of anti-
glaucoma treatments were also recorded, when applicable.
Preperimetric POAG patients were defined as having a
glaucomatous optic neuropathy in the absence of any other
causes of secondary glaucoma, based on abnormal optic disc
cupping (vertical cup-disc ratio>0.7) and/or neuroretinal rim
notching, with thinning of the RNFL on HD-OCT, and visual
field results, of each eye, that do not meet the minimum
criteria for diagnosing acquired glaucomatous damage based
on Hodapp-Parish-Anderson’s (H-P-A) criteria.27 In addition,
these patients were diagnosed with an IOP higher than 21 mm
Hg and open angles on gonioscopy. Patients and controls were
excluded if they had any associated ophthalmic conditions
(e.g., cataracts, myopia worse than 6 D, retinopathies,
potential alternative causes of optic neuropathy, and ocular
motor disorders), as well as psychiatric conditions or
neurologic disorders, including cognitive impairment or
dementia. POAG patients were on glaucoma medications
(e.g., brimonidine, prostaglandin analog, dorzolamide, and
timolol). Patients on psychotropics or other medications that
could affect alertness were also excluded. Informed consent
was obtained from the participants after explanation of the
nature and possible consequences of the study. The study
adhered to the tenets of the Declaration of Helsinki; the study
protocol was approved by the local Institutional Review Board
of the University Hospital of Angers, France.
Experimental Setting and Eye Movement
Recordings
Each participant was seated on a chair in a dark room with the
head stabilized by a chinrest. Binocular eye movements were
recorded using the Eyebrain T2 Tracker (SuriCog, Paris,
France), a CE-marked medical eye-tracking device. The record-
ing frequency of the system was set to 300 Hz and its precision
was 0.258 to 0.58 in controlled conditions. Participants
underwent binocular eye movement recordings while perform-
ing ocular motor paradigms presented on a 22-inch computer
screen (resolution 1920 3 1080; refresh rate 60 Hz), at 158 of
visual angle. Calibration of the system was performed at the
beginning of each block. During the calibration procedure,
participants were instructed to fixate various targets (0.58 in
diameter) displayed successively at 13 positions mapping the
screen. Each point had to be fixated for 250 ms for validation. A
polynomial function integrating five parameters was used to fit
the calibration data and to determine the visual angles. After
manual validation of the calibration procedure, each subject
underwent two ocular motor paradigms.
Prosaccades Paradigm
In this paradigm participants were instructed to fixate a central
circular fixation point of 0.58 in diameter for a pseudo-random
delay of 2000 to 3500 ms. Subsequently, the fixation point
disappeared making way after a 200-ms gap to a peripheral
visual stimulus. The peripheral stimulus consisted of a 0.58 red
filled square presented at 58, 108, 158, or 208 of horizontal
eccentricity. Stimuli were randomly presented to the left or
right of the fixation point for 1000 ms. Participants were
instructed to look toward the stimulus as quickly and
accurately after its presentation. Subsequently, the central
fixation target reappeared, signaling central refixation and the
beginning of the next trial. Each participant performed two
blocks of trials, separated by 2 minutes of rest. Each block
included presentation of 48 peripheral targets, 24 on each side
of the fixation target. This gap paradigm is designed to elicit
saccades with short latencies (80 to 130 ms) also coined as
‘‘Express Saccades’’ (ES) compared to regular saccades, which
have latencies between 150 and 200 ms.28
Antisaccades Paradigm
Antisaccades were explored using a classical gap paradigm.29
During the antisaccade task, participants were instructed to
fixate on a central target displayed for a pseudo-random time of
2000 to 3500 ms. Subsequent to the disappearance of the
central point (gap interval of 200 ms), a peripheral visual target
consisting of a 0.58 red filled square was presented at 128 of
horizontal eccentricity for 1000 ms. Participants were instruct-
ed to perform a saccade to the mirror location (same
amplitude, opposite direction) of the visual target as quickly
and accurately as possible.30 Thus, when the visual target
appeared on the right side, the subject had to perform a
saccade to the left, aiming at a diametrically opposed,
imaginary visual target. Subsequently to the disappearance of
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the peripheral visual stimulus, the central fixation target
reappeared signaling the start of the next trial. An initial
training block was performed to ensure that the instructions
were well understood. This paradigm involves two distinct,
successive processes: (1) inhibition of the ‘‘reflexive,’’
unwanted prosaccade toward the peripheral target, followed
by (2) execution of a voluntary, endogenous saccade in the
opposite direction. This task tests the integrity of the
‘‘decision-making’’ cortical networks, and is regularly used in
neurology to quantify the effects of age and neurodegenerative
diseases.31,32 Each participant performed two blocks of 12
randomly distributed horizontal antisaccades; each block was
separated by 2 minutes of rest.
Data Analysis
The algorithm used to detect saccades was adapted from
Nystro¨m and Holmqvist.33 Eye movements analysis was
performed using the MeyeAnalysis software (SuriCog), allowing
extraction of the saccades’ parameters from the acquired data.
This software automatically detects the onset and offset of each
saccade from both eyes using a built-in saccade detection
algorithm. The accuracy of automated saccade detection was
verified by experienced investigators (CL and DM). The latency,
average and peak velocities, amplitude, and consequently gain
(i.e., ratio of the amplitude of the saccade and the position/
amplitude of the peripheral visual target) of each saccade were
examined monocularly in the eye with the least artifacts (i.e.,
blinks, pupil detection aberrations). In total, the right eye was
used for saccade analyses in 28 participants (15 controls and 13
POAG). Saccades with latencies shorter than 50 ms or longer
than 500 ms were excluded from the analysis. The percentage
of ES correctly directed to the visible stimulus was also
calculated. In the antisaccade task, we analyzed the percentage
of antisaccade errors, as well as the latency and average velocity
of each correct antisaccade. A correct antisaccade was defined
as a saccade made in the opposite direction to the visible target,
and an incorrect antisaccade was defined as a saccade made
toward the target. Differences in demographics and compre-
hensive ophthalmologic examination of the eyes used in the
saccade analyses were compared between groups using a Mann-
Whitney U-test or a v2 test. The median of the absolute values of
prosaccade parameters was calculated for each participant as a
function of the eccentricity of the target cue and consequently
compared using a 2-way repeated-measures analysis of variance
(2-way RM-ANOVA) with position/amplitude of the visual target
and condition (control, POAG) as factors. For those compari-
sons in which the omnibus test reached statistical significance,
pairwise multiple comparison procedures were performed
using the Holm-Sidak method. Percentages of ES were
compared between groups using a v2 test. Comparison of
incorrect antisaccade percentage, velocity, and latency was
performed using either a Student’s t-test or a Mann-Whitney U-
test depending on the distribution of the data. Demographics
and ophthalmologic examination results are represented as
median (interquartile range [IQR]). Pro- and antisaccade
parameters and data in figures are represented as mean
(standard deviation [SD]). Statistical analyses and figures were
performed using SigmaPlot v12.0 (Systat Software, Chicago, IL,
USA).
RESULTS
Sixteen patients (65.0 [12.8] years, six males) with bilateral
preperimetric POAG and 16 age-matched healthy controls
(65.5 [14.3] years, seven males) were included in this study.
Patients and controls were not different in terms of BCVA,
central corneal thickness, visual fields’ mean deviation (HVF-
MD), pattern standard deviation (HVF-PSD), visual field index
(VFI), and IOP as POAG patients were on glaucoma medica-
tions. Compared to controls, patients with POAG had an
overall reduced RNFL thickness (RNFL-T; U ¼ 59.5, P ¼ 0.01)
particularly in the inferior (U¼ 66.0, P¼ 0.02) and superior (U
¼ 40.5, P ¼ 0.001) quadrants. A detailed description of the
demographics and ophthalmic appraisals in all participants is
provided in Table 1.
Prosaccades
A total of 1337 prosaccades were analyzed in the POAG group
and 1402 in the healthy control group (Table 2). There was an
effect of visual target position (amplitude) on saccade latency
in both groups, with 158 and 208 saccades having longer
latencies compared to 58 and 108 saccades (F[3, 30]¼ 20.19, P
< 0.001). Although the latency profile of POAG patients was
skewed toward faster saccades and a higher percentage of ES
(18.6%) compared to controls (15%; v2 ¼ 6.25, P¼ 0.012; Fig.
1A), when the data were analyzed per subject (Fig. 1B), the
latency of prosaccades was not different between POAG
patients and controls (F[1, 30] ¼ 1.11, P ¼ 0.30). The average
velocity of saccades increased as a function of amplitude in
both groups (F[3, 30]¼ 298.27, P <0.001). Average velocity of
prosaccades was reduced by 35.38/s on average across different
amplitudes in POAG patients compared to controls (F[1, 30]¼
5.39, P ¼ 0.03; Fig. 2). This reduction in average velocity was
independent of the amplitude of the saccade (F[3, 30]¼1.43, P
¼ 0.24). There was no difference between groups in peak
saccade velocity (F[1, 30]¼ 3.75, P¼ 0.06). The amplitudes of
the saccades were reduced in POAG patients compared to
controls (F[1, 30] ¼ 8.31, P ¼ 0.007) at 108, 158, and 208 (Fig.
3A). Consequently, saccade gain was reduced in patients
compared to controls (F[1, 30] ¼ 7.55, P ¼ 0.01; Fig. 3B).
Saccades performed by POAG patients were hypometric (gain
<1) when the peripheral visual targets were presented at 108,
158, and 208, whereas the saccades performed by controls were
hypermetric (gain >1) at visual target amplitudes of 58, 108,
and 158. Controls performed 18% more hypermetric saccades
(at least 10% off target) compared to POAG (Figs. 3A, 3B).
TABLE 1. Demographics and Ocular Characteristics of the POAG and
Control Groups Using the Eyes Utilized in the Saccades Analyses
Demographics and
Ocular Characteristics Control POAG P Value
Age, y 65.5 (14.3) 65.0 (12.8) 0.93
Sex 7M, 9F 6M, 10F 0.72‡
BCVA, logMAR 0.0 (0.0) 0.0 (0.0) 0.40
HVF-MD, dB 0.2 (2.3) 0.7 (2.0) 0.83
HVF-PSD, dB 1.7 (0.8) 2.0 (0.8) 0.21
VFI, % 99.0 (2.0) 98.5 (3.0) 0.31
IOP, mm Hg 15.0 (5.5) 15.0 (2.0) 0.86
RNFL-T global, lm 89.0 (9.3) 80.5 (13.8) 0.01*
RNFL-T inf, lm 118.5 (25.3) 94.5 (33.3) 0.02*
RNFL-T sup, lm 115.0 (15.0) 94.0 (21.5) 0.001†
RNFL-T nas, lm 64.5 (11.5) 66.0 (10.3) 0.91
RNFL-T temp, lm 60.5 (6.5) 59.0 (12.3) 0.68
Data are represented as median (IQR) and compared using the
Mann-Whitney U-test. dB, decibel; F, females; HVF, Humphrey visual
field; M, males; MD, mean deviation; RNFL–T, retinal nerve fiber layer
thickness; inf, inferior quadrant; sup, superior quadrant; nas, nasal
quadrant; temp, temporal quadrant; PSD, pattern standard deviation.
* P < 0.05.
† P < 0.01.
‡ Statistics done using a v2 test.
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Antisaccades
A total of 384 antisaccades trials were analyzed, including 192
trials in the POAG group and 192 trials in the control group.
On average, 40.6% of the antisaccade trials performed by the
POAG group were erroneous. This percentage of antisaccade
errors in the POAG group was significantly increased by 17.2%
compared to controls (23.4%; t¼ 2.05, P¼ 0.04; Fig. 4). There
was no difference between groups in the latency and average
velocity of correct (t ¼ 0.14, P ¼ 0.89; U ¼ 115, P ¼ 0.86,
respectively) and the latency of incorrect antisaccades (U ¼
110.5, P ¼ 0.9).
DISCUSSION
This study demonstrates that patients with early-stage POAG,
with no detectable glaucomatous visual field loss on standard
automated white-on-white perimetry, display abnormal pat-T
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FIGURE 1. Distribution and differences in saccade latencies between
controls and POAG patients. (A) Distribution of prosaccade latencies in
both groups. Overall preperimetric POAG patients displayed a higher
percentage of ES (18.6%; observation percentage within the gray area)
compared to the control group (15%; v2 ¼ 6.25, P¼ 0.01). When data
were analyzed per individual (B), the latency of prosaccades was not
different between the POAG and controls (F[1, 30] ¼ 1.11, P¼ 0.30).
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terns of saccadic eye movements compared to age-matched
controls. Preperimetric POAG patients performed slower and
hypometric saccades compared to controls during the
prosaccade task. In the antisaccade paradigm, POAG patients
also exhibited an inability to suppress unwanted reflexive
saccades to peripheral cues, committing significantly more
errors than controls. Taken together, our findings suggest that
visual field loss is not the sole contributor to disrupted ocular
motor behavior in early POAG. These disruptions could
originate from a decreased ocular motor inhibition and altered
neuronal signaling.
The network involved in reflexive prosaccade generation
includes cortical (primary visual, extrastriate, and parietal
cortices, and frontal and supplementary eye fields) and
subcortical structures (striatum, thalamus, superior colliculi
[SC], and cerebellar vermis).12 Dysfunction in any of these
structures could lead to faulty eye movements.12,13 In our
paradigm, POAG patients exhibited a reduction in the velocity
and amplitude of saccades compared to age-matched controls.
Amongst possible brain regions responsible for such defects in
POAG, the SC stand out as the most conspicuous. In fact, the
SC have been implicated in the amplitude and velocity of
impending saccades,34,35 and are targets of almost 10% of the
RGC axons in primates, and the primary targets of RGC axons
in rodents.36 Electrophysiological and structural changes occur
within the SC in a rodent model of glaucoma.37,38 Slowed
saccades could also arise from a reduced activation of burst
neurons or inhibitory omnipause neurons in the pontine
reticular formation. This structure has a predominant role in
fixation, and the generation and velocity of saccades, and
receives a main input from the SC.
The extent of reduction in saccade velocity observed in pre-
perimetric POAG patients is comparable to that observed
under intoxication39–41 or sedation.42 In fact, the 14.1%
reduction in average velocity denoted in POAG patients here
is even more prominent than that observed with 0.06% to
0.12% blood alcohol level (9%).39 This suggests that visual field
loss might not be the sole rationale for increased driving lapses
and motor vehicle accidents in glaucoma patients.43,44 Further
investigations in simulated driving situations are essential to
elucidate ocular movement and driving strategies in early-stage
glaucoma. It is worth mentioning that, given the established
relationship between saccade velocity and amplitude,45
saccade hypermetria in controls could be a factor in the
increased average velocity observed in that group. Saccade
hypermetria in healthy participants is dependent upon the
experimental paradigm and research settings,46 and has
previously been to associated with a top-down/predictive
component in self-paced saccades.47,48 Whether POAG pa-
FIGURE 3. Amplitude and gain of prosaccades in controls and POAG patients. (A) The amplitudes of saccades performed by POAG patients were
significantly reduced compared to controls when the target was presented at 108, 158, and 208 of eccentricity (F[1, 30] ¼ 8.31, P ¼ 0.007).
Consequently, saccade gain (B) was reduced in POAG patients compared to controls (F[1, 30] ¼ 7.55, P ¼ 0.01). The difference in gain between
groups was independent of the amplitude of the visual target (F[3, 30]¼0.06, P¼0.98). On average, POAG patients performed hypometric saccades
when the visual target was presented at 108, 158, and 208 from the central fixation point, whereas controls performed hypermetric saccades when
the visual target was presented at 58, 108, and 158 of eccentricity.
FIGURE 2. Average velocity of prosaccades in controls and POAG
patients. The increase in the amplitude of the visual target was
associated with an increase in the velocity of the saccades in both
groups (F[3, 30]¼ 298.27, P < 0.001). POAG patients displayed slower
saccades compared to controls (F[1, 30] ¼ 5.39, P ¼ 0.03). The
reduction in saccadic velocity was not dependent of the amplitude of
the saccades (F[3, 30] ¼ 1.43, P ¼ 0.24).
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tients show reduced predictive pacing urge in the prosaccade
paradigm remains to be clarified.
In addition to engaging similar brain regions to prosaccades,
a correct antisaccade involves neural activity changes in
regions such as the prefrontal and cingulate cortices, and
requires inhibition of a reflexive, unwanted saccade toward the
cue, prior to execution of an appropriate endogenous saccade
in the opposite direction.15,49 The antisaccade paradigm is
widely used to test cortical networks involved in this ‘‘decision-
making’’ process, which is abnormal in neurodegenerative
disorders,50 in multiple sclerosis,51 in psychiatric diseases, and
with aging.30 Here we show that preperimetric POAG is
associated with an increased number of unwanted reflexive
saccades. Among the various putative causal explanations, we
formulate the hypothesis that POAG may be associated with a
dysfunctional cerebral inhibition, leading to disrupted control
of reflexive eye movements. In POAG, structural changes have
been found in the LGN and in the primary visual areas,
presumably as a result of secondary anterograde trans-synaptic
degeneration.3 Recent multimodal, cerebral MRI and diffusion
tensor imaging studies have shown diffuse structural and
functional changes in the brains of patients with different
stages of glaucoma.10,11 These changes affected visual and
nonvisual structures in the brain. Beyond atrophy of the visual
cortex, these studies disclosed atrophy of scattered, distant
gray matter regions such as the frontoparietal cortex,
hippocampi, and cerebellar cortex, and decreased functional
connectivity in visual, working memory and dorsal attention
networks. The same study in glaucoma disclosed altered
integrity of the superior longitudinal fascicle, resulting in
decreased fractional anisotropy.11 This fascicle is involved in
providing information regarding perception of visual space to
the prefrontal cortex, which in turn is responsible for the
planning phase of an antisaccade.52 Furthermore, the white
matter of the precuneus showed abnormalities even in early-
stage POAG.11 This parietal brain structure has major
subcortical connections in brainstem structures with strong
oculomotor characteristics, such as the pretectal area, the SC,
and the nucleus reticularis tegmenti pontis.53–55
Given the developmental, physiological, and anatomical
features that the retina shares with the brain,56 it is not
surprising that functional changes affecting the retina could
also translate into cerebral dysfunctions and vice versa. In line
with this, evidence of a close link between glaucoma and
various neurodegenerative diseases have been reported in a
number of recent experimental studies,57–59 and the preva-
lence of glaucoma seems to be higher in Alzheimer’s disease
patients than in the normal population.60 Furthermore, a
thinning of the RGC axons has also been observed in a number
of neurodegenerative conditions such as Alzheimer’s and
Parkinson’s diseases.22,61 The reduced saccadic velocity and
increased antisaccade errors associated to a deficit in reflexive
saccade suppression we report in POAG patients, also
represent hallmarks of neurodegenerative diseases like Parkin-
son’s and Alzheimer’s diseases, progressive supranuclear palsy,
or even Huntington’s disease.62–64 Such coherence in early eye
movement symptoms between early POAG and neurodegener-
ative diseases, although inconclusive, deserves further atten-
tion to elucidate mechanisms associating glaucoma and
neurodegenerative diseases. The understanding of such com-
mon pathophysiological pathways could provide valuable
targets for novel therapeutics.
Besides the aforementioned plausible liaisons between
altered saccadic eye movements and cerebral aberrations
occurring in POAG, we cannot exclude a potential repercus-
sion of undiagnosed visual processing abnormalities observed
in early glaucoma65–68 (i.e., chromatic aberrations and reduc-
tion in contrast sensitivity) on the saccadic eye movements of
preperimetric POAG patients included in this study. The extent
of impact of such inferences on different saccadic parameters
remains to be elucidated in preperimetric POAG.
Irrespective of the physiological origins of altered saccadic
eye movements in POAG, early detection remains essential to
slow the progression of the disease. As the cost of treating
glaucoma increases by 46% after the occurrence of vision
loss,69 delaying disease-related vision loss in POAG is not solely
critical to maintain patients’ quality of life but also to reduce
associated health-economic burdens. Screening for early-stage
POAG using saccadic eye movements can potentially comple-
ment ongoing endeavors for a timely detection of this
debilitating disease. Such approaches have previously been
investigated in more advanced stages of glaucoma.70
This study has a few limitations that should be reported.
First, even though the SITA Fast algorithm is an accepted
screening strategy for patients who are unable to maintain
long-term attention, it may be less sensitive than SITA Standard,
and could therefore underestimate visual field loss. Here,
POAG patients underwent two HVF tests on two separate
occasions prior to their inclusion in the study. Only patients
whose visual field did not meet the minimum H-P-A criteria for
acquired glaucomatous visual fields damage were included.
Even though these criteria are known to be strict and could
suggest a significant deterioration where there is none,26 we
cannot exclude that some of our POAG participants could have
had very early, subthreshold, visual field loss. Second, this
observational study has a limited number of participants and
unlike other studies, does not provide information on eye
movements in real-life situations.18,70 When assessed in more
realistic settings (e.g., the head not stabilized by a chinrest),
parameters such as head movements, for example, could reveal
peculiar strategies adopted by preperimetric POAG patients to
compensate for impaired ocular motility even for minimal gaze
shifts. Nevertheless, using gold standard paradigms specifically
designed for the fine quantification of saccades in controlled
conditions, we have reduced interindividual variability and
yielded significant findings with a limited number of partici-
pants. Third, we cannot exclude a possible effect of glaucoma
medication on saccades. To our knowledge, however, there are
no reports on medication (e.g., prostaglandin analogs, a
agonists, b blockers) and eye movement in glaucoma. Further
investigations on a larger population of POAG patients are
required to clarify this matter. Finally, since we did not
compare the cognitive capabilities of our age-matched partic-
FIGURE 4. Antisaccade errors in controls and POAG patients. (A) On
average, 40.6% of the antisaccade trials performed by the POAG group
were erroneous. This percentage of antisaccade errors was significantly
increased by 17.2% compared to controls (23.4%; t¼ 2.05, P ¼ 0.04).
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ipants, we acknowledge that possible age-related infraclinical
cognitive impairments could contribute to the variability in
saccadic parameters observed in controls and POAG groups.
In conclusion, this study provides new insight on saccadic
eye movement changes in POAG with no detectable visual field
loss on standard automated perimetry. These abnormal eye
movements may occur as a result of altered neural signaling
and disrupted inhibition of unwanted reflexive saccades, and
might provide a new window into understanding the
pathophysiology of glaucoma. Additional studies are needed
to delineate the real-life consequences and neural basis of eye
movements abnormalities associated with this irreversible
ocular disease even at its earliest stages.
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